Project Number 3R01CA225830-05S1 Agency/Funding Organization NCI Funding Year 2022 View Full Project Details for Determining the mechanisms by which bone morphogenetic protein inhibition promotes survival/neurogenesis and to trigger AMPK hyperactivation that includes neuronal and cancer death cell Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies d. Prions Researcher and Organization Principal Investigator LANGENFELD, JOHN Principal Investigator First Name JOHN Principal Investigator Last Name LANGENFELD Awardee Organization RBHS -CANCER INSTITUTE OF NEW JERSEY Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $391,156 Funding Organization Agency/Funding Organization NCI Funding Organization Country United States Program Official AGYIN, JOSEPH KOFI
